RTALB Stock Overview
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₺12.85 |
52 Week High | ₺21.20 |
52 Week Low | ₺6.50 |
Beta | 0.19 |
1 Month Change | 3.80% |
3 Month Change | -15.40% |
1 Year Change | 60.83% |
3 Year Change | 27.80% |
5 Year Change | 2,115.15% |
Change since IPO | 880.47% |
Recent News & Updates
Recent updates
Shareholder Returns
RTALB | TR Biotechs | TR Market | |
---|---|---|---|
7D | -1.6% | 1.5% | 3.2% |
1Y | 60.8% | -21.6% | 131.1% |
Return vs Industry: RTALB exceeded the TR Biotechs industry which returned -21.7% over the past year.
Return vs Market: RTALB underperformed the TR Market which returned 122.6% over the past year.
Price Volatility
RTALB volatility | |
---|---|
RTALB Average Weekly Movement | 6.1% |
Biotechs Industry Average Movement | 7.6% |
Market Average Movement | 7.8% |
10% most volatile stocks in TR Market | 11.9% |
10% least volatile stocks in TR Market | 5.6% |
Stable Share Price: RTALB's share price has been volatile over the past 3 months.
Volatility Over Time: RTALB's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 54 | Resat Ultav | www.rtalabs.com.tr |
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, and swab products; and molecular biology products, such as nucleic acid isolation kits, real time PCR kits, and voltran viral load detection systems. The company was incorporated in 1996 and is based in Kocaeli, Turkey.
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Fundamentals Summary
RTALB fundamental statistics | |
---|---|
Market cap | ₺1.28b |
Earnings (TTM) | ₺249.44m |
Revenue (TTM) | ₺52.56m |
5.2x
P/E Ratio24.4x
P/S RatioIs RTALB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RTALB income statement (TTM) | |
---|---|
Revenue | ₺52.56m |
Cost of Revenue | ₺43.85m |
Gross Profit | ₺8.71m |
Other Expenses | -₺240.72m |
Earnings | ₺249.44m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 2.49 |
Gross Margin | 16.58% |
Net Profit Margin | 474.59% |
Debt/Equity Ratio | 6.1% |
How did RTALB perform over the long term?
See historical performance and comparison